Ticker > Company >

Eiko Lifesciences share price

Eiko Lifesciences Ltd.

BSE: 540204 SECTOR: Chemicals  10k   5   0

50.00
-0.50 (-0.99%)
BSE: Today, 03:55 PM

Price Summary

Today's High

₹ 51.99

Today's Low

₹ 50

52 Week High

₹ 74.88

52 Week Low

₹ 42

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

69.3 Cr.

Enterprise Value

55.96 Cr.

No. of Shares

1.39 Cr.

P/E

39.81

P/B

1.23

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  40.78

CASH

13.35 Cr.

DEBT

0 Cr.

Promoter Holding

36.23 %

EPS (TTM)

₹  1.26

Sales Growth

52.44%

ROE

1.88 %

ROCE

2.82%

Profit Growth

-2.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year52.44%
3 Year32.56%
5 Year138.12%

Profit Growth

1 Year-2.25%
3 Year6.95%
5 Year59.7%

ROE%

1 Year1.88%
3 Year2.86%
5 Year4.29%

ROCE %

1 Year2.82%
3 Year4.18%
5 Year5.04%

Debt/Equity

0

Price to Cash Flow

-9.79

Interest Cover Ratio

7.7643

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 36.23 0.00
Dec 2024 31.27 0.00
Sep 2024 24.40 0.00
Jun 2024 24.40 0.00
Mar 2024 24.23 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 32.557759338427% for the Past 3 years.
  • The company has significantly decreased its debt by 0.0536 Cr.
  • Company is virtually debt free.
  • Company has a healthy liquidity position with current ratio of 20.5576.
  • Promoter stake has increased from 24.4% to 31.27% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of 6.95050096931094% for the Past 3 years.
  • Company has a poor ROE of 2.85967273452303% over the past 3 years.
  • Company has a poor ROCE of 4.18293497871941% over the past 3 years
  • Company has negative cash flow from operations of -7.0799.
  • The company is trading at a high PE of 39.81.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
Net Sales 8.4 10.75 7.74 6.91 7.09
Total Expenditure 7.88 10.36 7.39 6.46 6.58
Operating Profit 0.52 0.39 0.35 0.45 0.51
Other Income 0.11 0.26 0.13 0.11 0.53
Interest 0.02 0.03 0.04 0.02 0.04
Depreciation 0.18 0.17 0.16 0.15 0.15
Exceptional Items 0 0 0 0 0.34
Profit Before Tax 0.42 0.46 0.28 0.38 1.2
Tax 0.11 0.12 0.07 0.1 0.3
Profit After Tax 0.31 0.35 0.21 0.28 0.9
Adjusted EPS (Rs) 0.24 0.27 0.16 0.22 0.65

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 0 11.99 25.41 18.32 27.93
Total Expenditure 0.17 11.47 24.1 17.36 26.32
Operating Profit -0.17 0.52 1.31 0.96 1.61
Other Income 0.43 0.46 0.67 0.85 0.18
Interest 0.07 0.09 0.48 0.16 0.15
Depreciation 0.06 0.06 0.56 0.63 0.66
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.13 0.83 0.94 1.03 0.98
Tax 0 0.22 0.24 0.26 0.23
Net Profit 0.13 0.61 0.71 0.77 0.75
Adjusted EPS (Rs.) 0.29 1.39 0.74 0.8 0.58

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.82 3.82 8.32 8.32 12.87
Total Reserves 1.66 8.71 20.31 21.11 37.81
Borrowings 0.2 0.13 0.05 0 0
Other N/C liabilities -0.05 -0.02 0.2 0.42 0.56
Current liabilities 0.08 3.96 6.01 1.2 1.5
Total Liabilities 5.71 16.59 34.89 31.04 52.74
Assets
Net Block 0.31 0.25 14.29 13.88 13.57
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.5 0.22 0.2 0.05 4.02
Loans & Advances 3.35 3.61 2.3 6.68 4.23
Other N/C Assets 1.45 1.81 5.67 1.12 0
Current Assets 0.1 10.7 12.44 9.3 30.93
Total Assets 5.71 16.59 34.89 31.04 52.74
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.13 0.83 0.94 1.03 0.98
Adjustment 0.06 -0.21 0.38 0.02 0.62
Changes in Assets & Liabilities 0.6 -1.27 -8.84 3.1 -8.65
Tax Paid -0.01 -0.18 -0.21 0.08 -0.03
Operating Cash Flow 0.77 -0.83 -7.73 4.22 -7.08
Investing Cash Flow -0.65 -2.94 0.59 0.87 -0.55
Financing Cash Flow -0.13 7.81 3.28 -4.7 20.36
Net Cash Flow -0.01 4.05 -3.85 0.4 12.73

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 24.23 24.40 24.40 31.27 36.23
bhavesh dhirajlal tanna 2.81 2.81 2.81 2.81 2.81
laxmikant kabra (huf) 10.08 10.24 10.24 10.24 10.24
laxmikant ramprasad kabra... 0.84 0.84 0.84 0.84 0.84
lenus finvest private lim... 10.14 10.14 10.14 17.01 17.01
siddhant laxmikant kabra 0.36 0.36 0.36 0.36 5.31
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 75.77 75.60 75.60 68.73 63.77
2b black bio llp - 14.73 - 14.79 9.95
ashika global finance pvt... - - - - 4.27
ashok vishwanath hiremath... 8.90 8.90 8.90 3.85 3.85
bhavinkumar vinaychand sh... 1.23 1.34 1.35 1.36 1.36
joyanta kumar jana - - 1.98 1.99 2.01
kaushik daga 2.30 2.30 2.30 2.30 2.30
parshva kumar daga 1.71 1.71 1.71 1.71 1.71
sivanesan sellappan - - - 1.44 1.44
sushila paraskumar daga 1.72 1.72 1.72 1.72 1.72
ashika global finance pvt... 4.15 - 4.27 4.27 -
2b black bio llp . 14.56 - 14.79 - -
v square pharmachem priva... 1.22 - 2.26 - -
aritro ashish roy 4.53 1.88 - - -
ashika global finance pvt... - 4.27 - - -
deepak jugalkishore chokh... 1.20 1.20 - - -
v square pharmachem priva... - 2.99 - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Eiko Lifesciences - Quaterly Results 14 May, 4:49 PM Eiko Lifesciences - Quaterly Results 14 May, 4:49 PM Eiko Lifesciences - Quaterly Results 14 May, 4:49 PM Eiko Lifesciences informs about disclosure 28 Mar, 5:34 PM Eiko Lifesciences informs about disclosure 26 Mar, 10:58 AM Eiko Lifesciences informs about disclosures 18 Mar, 10:51 AM Eiko Lifesciences informs about disclosure 13 Mar, 10:22 AM Eiko Lifesciences informs about disclosure 11 Mar, 12:39 PM Eiko Lifesciences informs about disclosure 5 Mar, 11:44 AM Eiko Lifesciences informs about disclosure 4 Mar, 4:44 PM Eiko Lifesciences informs about disclosure 27 Feb, 1:06 PM Eiko Lifesciences informs about disclosure 19 Feb, 12:14 PM Eiko Lifesciences - Quaterly Results 12 Feb, 8:44 PM Eiko Lifesciences - Quaterly Results 12 Feb, 8:44 PM Eiko Lifesciences’ arm enters into agreement with S J Logistics (India) 18 Dec, 3:10 PM Eiko Lifesciences incorporates new subsidiary company 6 Nov, 11:30 AM Eiko Lifesciences - Quaterly Results 19 Oct, 8:34 PM Eiko Lifesciences - Quaterly Results 19 Oct, 8:34 PM Eiko Lifesciences informs about disclosure 22 Aug, 5:33 PM Eiko Lifesciences - Quaterly Results 13 Aug, 6:07 PM Eiko Lifesciences - Quaterly Results 13 Aug, 6:07 PM Eiko Lifesciences informs about board meeting 5 Aug, 12:20 PM Eiko LifeSciences incorporates limited liability partnership 31 May, 10:41 AM Eiko Lifesciences - Quaterly Results 13 May, 6:25 PM Eiko Lifesciences - Quaterly Results 13 May, 6:25 PM Eiko Lifesciences informs about board meeting 6 May, 4:53 PM Eiko LifeSciences acquires 25.01% stake in Reflux Pharmaceuticals 19 Apr, 2:29 PM Eiko Lifesciences - Quaterly Results 8 Feb, 6:05 PM Eiko Lifesciences - Quaterly Results 8 Feb, 6:05 PM Eiko Lifesciences informs about outcome of board meeting 25 Jan, 4:11 PM Eiko Lifesciences informs about updates 25 Jan, 2:48 PM Eiko Lifesciences informs about newspaper publication 2 Jan, 6:02 PM Eiko Lifescience informs about newspaper advertisement 15 Dec, 3:25 PM Eiko Lifesciences informs about disclosure 27 Oct, 11:18 AM Eiko Lifesciences informs about disclosure 11 Aug, 2:23 PM Eiko Lifesciences informs about disclosure 3 Aug, 10:06 AM Eiko Lifesciences informs about disclosure 22 Jul, 11:17 AM Eiko Lifesciences informs about disclosure 21 Jul, 2:36 PM Eiko Lifesciences informs about disclosure 18 Jul, 10:42 AM Eiko Lifesciences - Quaterly Results 11 Jul, 6:06 PM Eiko Lifesciences - Quaterly Results 11 Jul, 6:06 PM Eiko Lifesciences - Quaterly Results 11 Jul, 6:06 PM Eiko Lifesciences inks pact to acquire 25.01% stake in Reflux Pharmaceuticals 18 May, 4:14 PM Eiko Lifesciences informs about closure of trading window 12 May, 4:05 PM Eiko Lifesciences - Quaterly Results 9 May, 5:30 PM Eiko Lifesciences - Quaterly Results 9 May, 5:30 PM Eiko Lifesciences - Quaterly Results 9 May, 5:30 PM Eiko LifeSciences enters into MoU with Vivacious Pharmatex 17 Mar, 4:09 PM Eiko Lifesciences informs about disclosures 6 Mar, 3:59 PM Eiko Lifesciences informs about postal ballot notice 1 Feb, 4:46 PM

Eiko Lifesciences Stock Price Analysis and Quick Research Report. Is Eiko Lifesciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Eiko Lifesciences stock price today is Rs 50. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Eiko Lifesciences . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Eiko Lifesciences has a PE ratio of 39.805747950004 which is high and comparatively overvalued .

  • Share Price: - The current share price of Eiko Lifesciences is Rs 50. One can use valuation calculators of ticker to know if Eiko Lifesciences share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Eiko Lifesciences has ROA of 1.794 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Eiko Lifesciences has a Current ratio of 20.5576 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Eiko Lifesciences has a ROE of 1.8764 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Eiko Lifesciences has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Eiko Lifesciences has reported revenue growth of 52.4409 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Eiko Lifesciences for the current financial year is 5.76598769034669 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Eiko Lifesciences is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Eiko Lifesciences is Rs 1.2561 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Eiko Lifesciences in Ticker for free. Also, one can get the intrinsic value of Eiko Lifesciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Eiko Lifesciences
X